NovoCure
$12.05
24H
Market Cap
Volume
Supply
Price Chart
About NovoCure - NVCR
Novocure Limited is a global oncology company specializing in the development of Tumor Treating Fields (TTFields), a unique cancer therapy that uses electric fields to disrupt cancer cell division and impede tumor growth. They aim to offer novel cancer treatment options based on this technology for multiple types of cancer.
What are NovoCure's core values and mission statement?
NovoCure Limited's mission statement centers around extending survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Their core values are focused on patients first, innovation, execution with excellence, and long-term value creation for stakeholders, all while fostering a respectful and collaborative work environment.
Who founded NovoCure and when?
Novocure Limited was founded by Professor Yoram Palti in 2000 with the goal of developing his proprietary tumor treating fields (TTFields) technology to treat cancer.
Who leads NovoCure?
As of the last update, Asaf Danziger serves as the CEO of NovoCure Limited, leading the company in its efforts to develop novel therapies for cancer treatment.
Where is NovoCure located, and what is its base country?
NovoCure Limited is headquartered in Saint Helier, Jersey, which is its base country.
On which exchanges is NovoCure traded?
NovoCure Limited is traded on the NASDAQ under the ticker symbol NVCR.
Historical data
NovoCure (NVCR) Price Live Data
The live price of NovoCure (NVCR) is $12.05, with a trading volume of 565,520 in the last 24 hours. Wrapstocks updates the NVCR price in real-time. NovoCure is up 1.86% in the last 24 hours. The company has a live market cap of $1,290,470,656.00 and a supply of 107,093,000 NVCR stocks.
NovoCure (NVCR) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 14 hours and 3 minutes.
